AnYoufan ® Escitalopram Oxalate Tablets
Selected in the 1st Round of National Volume-Based Procurement (Continuation)
National Essential Drug, Category A under National Medical Insurance
[Drug Name]
Generic name: Escitalopram Oxalate Tablets
[Indications]
For the treatment of depressive disorders, and for panic disorder with or without agoraphobia.
[Dosage and Administration]
Administration: Oral, may be taken with food.
• Depression
Once daily. Usual dose: 10 mg daily. Depending on individual response, the maximum daily dose may be increased to 20 mg. Antidepressant efficacy is usually seen within 2–4 weeks. After symptom remission, treatment should continue for at least 6 months to consolidate therapeutic effect.
• Panic Disorder (with or without agoraphobia)
Once daily. Initial dose: 5 mg daily for the first week, increased to 10 mg daily thereafter. Depending on response, the maximum daily dose may be increased to 20 mg. Optimal efficacy is usually achieved after about 3 months of treatment. The treatment course generally lasts several months. (Refer to package insert for details.)
[Contraindications]
1. Contraindicated in patients allergic to the active ingredient or any excipients.
2. Drug interactions (see [Precautions] and [Drug Interactions]).
3. For detailed information on adverse reactions, drug interactions, and precautions, please refer to the Chinese package insert.
[Specification]
10 mg (calculated as C20H21FN2O )
[Shelf Life]
36 months
[Approval Number]
National Medical Products Administration Approval Number: H20213193
Fujian Haixi New Pharmaceutical Creation Co., Ltd. Fujian ICP Record No. 12015727 Internet Drug Information Service Qualification Certificate No.: (Min) - Non-operating-2023-0063
Some of the text and pictures on this site are from the Internet and are only used for sharing and learning. If your rights and interests are infringed, please inform us in time, and this site will deal with or replace them in time.
